USPTO

AXIM Biotech to Get U.S. Patent Covering All Cannabinoids in Its Chewing Gums

AXIM BiotechnologiesĀ announced that theĀ United States Patent and Trademark Office (USPTO) will be issuing a patent coveringĀ all cannabinoids ā€” both natural and synthetic ā€” Ā used in a chewing gum delivery system that may be included in itsĀ cannabinoid-containing, controlled-release chewing gum products. The USPTO has given the company aĀ Notice of…

RedHill’s Experimental MS Therapy, RHB-104, Receives Notice of Allowance on U.S. Patent

RedHill Biopharma, Ltd., an Israeli biopharmaceutical company focused on the development and commercialization of oral-administered small-molecule medicines for the treatment of inflammatory and gastrointestinal diseases, recently announced it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent covering its…